Safety and feasibility of dobutamine stress echocardiography in patients with implantable cardioverter defibrillators.
Coronary artery disease is the underlying etiology of left ventricular dysfunction and arrhythmias in most patients who receive implantable cardioverter defibrillators (ICDs). The aim of this study was to assess the safety and feasibility of dobutamine stress echocardiography (DSE) in patients with an ICD. DSE (dobutamine up to 50 microg/kg/min, atropine up to 2 mg) was performed in 87 patients with an ICD and known or suspected coronary artery disease. The ICD was inactivated before the stress test and reactivated after the study; no serious complications occurred. DSE is a safe and feasible method for evaluating myocardial ischemia in patients with an ICD.
Elhendy
Abdou
A
Department of Cardiology and Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska 68198-2265, USA. Aelhendy@unmc.edu
Windle
John
J
Porter
Thomas R
TR
D000368:Aged; D001285:Atropine / Q000008:administration & dosage; D017147:Defibrillators, Implantable; D004280:Dobutamine / Q000009:adverse effects; D025401:Echocardiography, Stress / Q000009:adverse effects; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D008297:Male; D017202:Myocardial Ischemia / Q000000981:diagnostic imaging*
D004280:Dobutamine; D001285:Atropine